Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00224393
Status:
COMPLETED
Last Update Posted:
2023-05-30
First Post:
2005-09-21
Brief Title:
Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis
Sponsor:
The Cleveland Clinic
Organization:
The Cleveland Clinic
Organization Data
Organization:
The Cleveland Clinic
Class:
OTHER
Study ID:
MC018A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Cleveland Clinic
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None